Literature DB >> 3677545

A genetic polymorphism of the N-oxidation of trimethylamine in humans.

M Al-Waiz1, R Ayesh, S C Mitchell, J R Idle, R L Smith.   

Abstract

Trimethylamine (TMA) and its N-oxide (TMAO) are normal components of human urine. They are present in the diet and also derived from the enterobacterial metabolism of precursors such as choline. Dietary TMA is almost entirely metabolized to and excreted as TMAO. However, the extent to which TMA undergoes N-oxidation appears to be polymorphic in a British white population study (n = 169). Two propositi were identified with relative TMA N-oxidation deficiency that was further confirmed by oral challenge with TMA (600 mg). The study of the families of the two propositi, as well as those of two identified subjects with trimethylaminuria, under both normal dietary conditions and after oral TMA challenge strongly indicates that the conditions of impaired N-oxidation is inherited as a recessive trait. It is proposed that the N-oxidation of TMA in humans is polymorphic and under single gene diallelic control in which individuals who are homozygous for the variant allele exhibit marked N-oxidation deficiency and trimethylaminuria.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3677545     DOI: 10.1038/clpt.1987.201

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  23 in total

1.  Clinical utility gene card for: trimethylaminuria.

Authors:  Elizabeth A Shephard; Eileen P Treacy; Ian R Phillips
Journal:  Eur J Hum Genet       Date:  2011-11-30       Impact factor: 4.246

2.  Drug metabolism and pharmacogenetics: the British contribution to fields of international significance.

Authors:  John Caldwell
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

3.  Fish odor syndrome.

Authors:  H U Rehman
Journal:  Postgrad Med J       Date:  1999-08       Impact factor: 2.401

4.  Variable metabolism of pinacidil: lack of correlation with the debrisoquine and trimethylamine C- and N-oxidative polymorphisms.

Authors:  R Ayesh; M Al-Waiz; A McBurney; S C Mitchell; J R Idle; J W Ward; R L Smith
Journal:  Br J Clin Pharmacol       Date:  1989-04       Impact factor: 4.335

5.  The fish odour syndrome: biochemical, familial, and clinical aspects.

Authors:  R Ayesh; S C Mitchell; A Zhang; R L Smith
Journal:  BMJ       Date:  1993-09-11

6.  The fish odour syndrome.

Authors:  V Walker
Journal:  BMJ       Date:  1993-09-11

7.  Molecular cloning, sequence characterization, SNP detection, and tissue expression analysis of duck FMO3 gene.

Authors:  Peng Wang; Jiangxia Zheng; Lujiang Qu; Ling Lian; Guiyun Xu; Ning Yang
Journal:  Mol Cell Biochem       Date:  2013-04-28       Impact factor: 3.396

8.  Congenital intrahepatic portocaval shunt associated with trimethylaminuria.

Authors:  M S Fernández; C Gutiérrez; J J Vila; A López; V Ibáñez; C Sangüesa; J Lluna; J E Barrios
Journal:  Pediatr Surg Int       Date:  1997-02       Impact factor: 1.827

9.  Trimethylaminuria: the detection of carriers using a trimethylamine load test.

Authors:  M al-Waiz; R Ayesh; S C Mitchell; J R Idle; R L Smith
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

10.  Metabolism of verapamil in a family pedigree with deficient N-oxidation of trimethylamine.

Authors:  R Ayesh; H Kroemer; M Eichelbaum; R L Smith
Journal:  Br J Clin Pharmacol       Date:  1991-06       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.